Stock Market
-
The plan to sell shares in Korea Zinc has been suspended due to the regulator’s review request, the filing said.
SEOUL (Reuters) – Korea’s new stock exchange program announced on Oct. 30 has been suspended due to a review request…
Read More » -
Emerson offers to buy all of AspenTech in $15 billion deal to sharpen focus on automation By Reuters
Written by Nathan Gomes (Reuters) – Emerson Electric on Tuesday proposed to buy all of AspenTech it does not own…
Read More » -
JPMorgan raises Leidos target to $205 on strong Federal IT trend By Investing.com
On Tuesday, JPMorgan revised its price target Leidos Holdings (NYSE: NYSE:), a company specializing in information technology services for the…
Read More » -
Fast food stocks face obstacles to growth By Investing.com
The Wendy’s Company (NASDAQ: ), a dominant player in the quick service restaurant (QSR) industry, finds itself navigating a complex…
Read More » -
How much would I need to invest in income shares to earn £300 a month?
Image source: Getty Images On top of it, income shares are ridiculous. Park a little extra money in a company…
Read More » -
navigating hot water By Investing.com
Norwegian Cruise Line Holdings (NYSE: ), a major player in the cruise industry, has been going through challenging waters in…
Read More » -
Here’s how I can follow Warren Buffett to start building income in 2025
Image source: Getty Images Rome was not built in a day, and there is no way to get it. For…
Read More » -
Balchem’s forecast revised higher for stronger-than-expected Q3 profit by Investing.com
On Tuesday, HC Wainwright maintained a buy rating on Balchem (NASDAQ:) Corporation (NASDAQ:BCPC) and raised its 12-month price target to…
Read More » -
2 FTSE dividend stocks yielding over 6% with P/Es under 9!
Image source: Getty Images I like to shop cheap FTSE 100 high yield dividend stocks, and these two caught my…
Read More » -
JPMorgan sees “potential for success” in CAMP4 stock, big bet on RNA tech By Investing.com
On Tuesday, JPMorgan initiated coverage on NASDAQ:CAMP stock, CAMP4 Therapeutics Corp, with an Overweight rating and a $23.00 price target.…
Read More »